483 related articles for article (PubMed ID: 28243083)
1. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe
Shen JM; Li XX; Fan LL; Zhou X; Han JM; Jia MK; Wu LF; Zhang XX; Chen J
Int J Nanomedicine; 2017; 12():1183-1200. PubMed ID: 28243083
[TBL] [Abstract][Full Text] [Related]
2. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment.
Hu G; Chun X; Wang Y; He Q; Gao H
Oncotarget; 2015 Dec; 6(38):41258-74. PubMed ID: 26517810
[TBL] [Abstract][Full Text] [Related]
3. Size-shrinkable and protein kinase Cα-recognizable nanoparticles for deep tumor penetration and cellular internalization.
Ma JB; Shen JM; Yue T; Wu ZY; Zhang XL
Eur J Pharm Sci; 2021 Apr; 159():105693. PubMed ID: 33383133
[TBL] [Abstract][Full Text] [Related]
4. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
5. Magnetite Nanoparticles and Spheres for Chemo- and Photothermal Therapy of Hepatocellular Carcinoma in vitro.
Jędrzak A; Grześkowiak BF; Golba K; Coy E; Synoradzki K; Jurga S; Jesionowski T; Mrówczyński R
Int J Nanomedicine; 2020; 15():7923-7936. PubMed ID: 33116509
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
Metin E; Mutlu P; Gündüz U
Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
Elbialy NS; Fathy MM; Khalil WM
Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid-Decorated Glycogen Nanoparticles for Stimuli-Responsive Drug Release and Synergetic Chemophotothermal Therapy of Hepatocellular Carcinoma.
Zhou J; Han Y; Yang Y; Zhang L; Wang H; Shen Y; Lai J; Chen J
ACS Appl Mater Interfaces; 2020 May; 12(20):23311-23322. PubMed ID: 32349481
[TBL] [Abstract][Full Text] [Related]
9. pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor.
Li XX; Chen J; Shen JM; Zhuang R; Zhang SQ; Zhu ZY; Ma JB
Int J Pharm; 2018 Jul; 545(1-2):274-285. PubMed ID: 29733971
[TBL] [Abstract][Full Text] [Related]
10. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
11. Surface charge-switchable polymeric magnetic nanoparticles for the controlled release of anticancer drug.
Shen JM; Yin T; Tian XZ; Gao FY; Xu S
ACS Appl Mater Interfaces; 2013 Aug; 5(15):7014-24. PubMed ID: 23815399
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of iron oxide nanoparticles with RGD-modified dendrimers for targeted tumor MR imaging.
Yang J; Luo Y; Xu Y; Li J; Zhang Z; Wang H; Shen M; Shi X; Zhang G
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5420-8. PubMed ID: 25695661
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin loaded magnetic Fe3O4/carboxymethylchitosan nanoparticles as tumor-targeted drug delivery system: Synthesis and in vitro characterization.
Li G; Cao L; Zhou Z; Chen Z; Huang Y; Zhao Y
Colloids Surf B Biointerfaces; 2015 Apr; 128():379-388. PubMed ID: 25779605
[TBL] [Abstract][Full Text] [Related]
14. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin.
Karimian A; Yousefi B; Sadeghi F; Feizi F; Najafzadehvarzi H; Parsian H
Chem Biol Interact; 2022 Jan; 351():109731. PubMed ID: 34728188
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-loaded Fe
Cheng C; Li C; Zhu X; Han W; Li J; Lv Y
J Biomater Appl; 2019 May; 33(10):1373-1381. PubMed ID: 30880566
[TBL] [Abstract][Full Text] [Related]
17. Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment.
Hu G; Zhang H; Zhang L; Ruan S; He Q; Gao H
Int J Pharm; 2015 Dec; 496(2):1057-68. PubMed ID: 26598487
[TBL] [Abstract][Full Text] [Related]
18. Elegant pH-Responsive Nanovehicle for Drug Delivery Based on Triazine Dendrimer Modified Magnetic Nanoparticles.
Landarani-Isfahani A; Moghadam M; Mohammadi S; Royvaran M; Moshtael-Arani N; Rezaei S; Tangestaninejad S; Mirkhani V; Mohammadpoor-Baltork I
Langmuir; 2017 Aug; 33(34):8503-8515. PubMed ID: 28732161
[TBL] [Abstract][Full Text] [Related]
19. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
20. Cell-Penetrating Peptidic GRP78 Ligand-Conjugated Iron Oxide Magnetic Nanoparticles for Tumor-Targeted Doxorubicin Delivery and Imaging.
Hasani M; Jafari S; Akbari Javar H; Abdollahi H; Rashidzadeh H
ACS Appl Bio Mater; 2023 Mar; 6(3):1019-1031. PubMed ID: 36862384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]